Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2025-12-25 @ 5:14 PM
Study NCT ID:
NCT06839703
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-02-21
First Post:
2025-02-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma
Sponsor:
Prof. Dr. Dirk Reinhardt
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-17
First Submit QC Date:
None
Study First Post Date:
2025-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-17
Last Update Post Date:
2025-02-21
Last Update Post Date Type:
ACTUAL